Abstract:OBJECTIVE To identify plasma biomarkers with specific relation to the various liver fibrosis stages that can be used to assess hepatitis B virus (HBV)-infected patients for non-invasive liver fibrosis and to evaluate the prognosis of the liver fibrosis. METHODS Plasma samples were collected from 80 HBV-positive patients at the Hepatitis Department of Shanghai Public Health Clinical Center between September 2008 and January 2011. The samples were grouped according to the patient's stage of hepatic fibrosis determined by liver biopsy: S0-1 (n = 40), S2-3 (n = 20), and S4 (n = 20). Each plasma sample was processed to remove the two most abundant proteins, albumin and immunoglobulin G (IgG), and then resolved by two-dimensional (2D) electrophoresis. ImageMaster 2D analysis software was used to identify differentially expressed proteins related to the liver fibrosis stages. After trypsin digestion, the differential proteins were identified by online reversed-phase nano-flow liquid chromatography coupled with electrospray ionization ion trap mass spectrometry (MS). RESULTS The patients in the three groups were not significantly different in age (range: 30-50 years; P = 0.053) or sex (x² = 0.155, P = 0.926). Low-abundance proteins were efficiently enriched by the albumin/IgG depletion method. Fourteen differentially expressed proteins were detected among the S0-1, S2-3 and S4 groups, all of which were identified by tandem MS and included fibrinogen gamma chain, haptoglobin, complement C3, Ig kappa chain C region, and apolipoprotein A-I. CONCLUSION Plasma proteomic analysis of chronic hepatitis B patients identified a panel of differentially expressed proteins related to different stages of liver fibrosis. These proteins may represent diagnostic and prognostic biomarkers of HBV-related hepatic fibrosis.

Proteomic analysis of plasma from heroin abuser sunder immobilized Ph gradients 4 -7

Blood Plasma Proteomic Changes in a Range of Ph4～7 among Heroin Abuser

Differential Proteome Profiling of Pleural Effusions from Lung Cancer and Benign Inflammatory Disease Patients

Altered Serum Microrna Expression Profile in Subjects with Heroin and Methamphetamine Use Disorder.

Profiling serum low molecular weight proteins in patients with chronic severe hepatitis

Serum cytokine and inflammatory markers in individuals with heroin use disorder: potential biomarkers for diagnosis and disease severity

Serum cytokines and inflammatory proteins in individuals with heroin use disorder: potential mechanistically based biomarkers for diagnosis

Metabonomic Study of Biochemical Changes in Human Hair of Heroin Abusers by Liquid Chromatography Coupled with Ion Trap-Time of Flight Mass Spectrometry

[Plasma Proteome Analysis of Chronic Hepatitis B Patients with Different Stages of Liver Fibrosis].

Serum Proteomics of Methamphetamine Addicts and Up-Regulation of Complement Factor H Related to Methamphetamine Addiction

Analysis of Low Abundance Diferential Proteins in Plasma from Hepatocellular Carcinomas Patients by Multi-dimensional Chromatography Tandem Mass Spectrometry

Analysis of Differentially Expressed Proteins Involved in Autoimmune Cirrhosis and Normal Serum by Itraq Proteomics

Proteomic Analysis of Individual Variation in Normal Livers of Human Beings Using Difference Gel Electrophoresis

Proteomic Analysis of the Serum in Patients with Idiopathic Pulmonary Arterial Hypertension

Heroin Abuse Results in Shifted RNA Expression to Neurodegenerative Diseases and Attenuation of TNFα Signaling Pathway

Applicability of ultra-performance liquid chromatography-tandem mass spectrometry for heroin profiling

Design and preparation of novel antibody system and application for the determination of heroin metabolites in urine by capillary electrophoresis

The primary research on different expressing of plasma proteomics in chronic severe hepatitis B

Neurotransmitter system aberrations in patients with drug addiction

Alpha‐1 Antitrypsin Variants in Plasma from HIV‐infected Patients Revealed by Proteomic and Glycoproteomic Analysis

Purification and identification of serum protein biomarkers with relation to portal vein tumor thrombi screened by SELDI-TOF MS